Oxidative stress in the CNS acts as a persistent inflammatory trigger by activating brain-resident immune cells, particularly microglia and astrocytes
Clinical trials demonstrate that semaglutide can produce approximately 15% body weight reduction over 68 weeks, while tirzepatide can achieve about 21% reduction over 72 weeks when combined with lifestyle modifications in people without diabetes
Cognitive Function EnhancementAcetyl-L-Carnitine efficiently crosses the blood-brain barrier, supporting neurotransmitter activity, mental clarity, and focus
Thus, lipid-driven eryptosis is mainly attributed to ceramide generation in the plasma membrane (Fig
We take a transparency-first approach
"Others may require dose escalation or maximal doses to experience an effect, and studies show that 20% of individuals are complete non-responders, meaning they do not experience any weight reduction despite maximal doses of the drug." With this in mind, the average experience with GLP-1s includes "a gradual onset of benefits," says Dr